Page 15 - Hercules Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hercules Capital, Inc (NYSE:HTGC) Given Consensus Recommendation of Hold by Brokerages

Hercules Capital, Inc (NYSE:HTGC) Given Consensus Recommendation of Hold by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerMelia wealthHercules capital incGoldman sachs group incInternational assets investment managementWells fargo companyHercules capital company profileAssociates corpAtria wealth solutions incHercules capitalGet free reportWells fargoAssets investment managementWealth solutionsGoldman sachs groupSachs group

High Dividend Picks, Anyone?

High Dividend Picks, Anyone?
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesDwayne hyzakAres capital corporationFund of fundsIndirect fund expensesCapital corpFund feesRealty incomeVanguard real estate index fundBdcs business development companiesEnd fundSpirit realty capitalCohen steers quality income realty fund incSeeking alphaSteers quality income realty fundClosed end fund

Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline - Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI)

Beckley psytechAtai life sciencesHercules capitalBenzinga cannabis capitalContinued commitment to transforming mentalFlorian brandTreatment resistant depressionAlcohol use disorderMajor depressive disorderOpioid use disorder

Atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights

Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003 .

United statesBeckley psytechExchange commissionSchizophrenia international researchDemerx ib incHercules capital incSecurities exchangeLife sciencesSociety in florence italy onFlorian brandChief executive officerTreatment resistant depressionAlcohol use disorderMajor depressive disorderPsilocybin therapyPivotal trial

atai Life Sciences Reports Fourth Quarter and Full Year

Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment.

United statesBeckley psytechLife sciencesSecurities exchangeSchizophrenia international researchHercules capital incDemerx ib incExchange commissionSociety in florence italy onFlorian brandChief executive officerTreatment resistant depressionAlcohol use disorderMajor depressive disorderPsilocybin therapyPivotal trial